Summary
Researchers identified 81 plant species in the Ayurvedic Pharmacopoeia of India (API) with therapeutic indication for Prameha, a condition that resembles Diabetes Mellitus. Among the 394 species in the API, only Curcuma longa and Cymbopogon martini are recognized in the Brazilian Pharmacopoeia (BP). While C. longa is described as anti-inflammatory and anti-dyspeptic, C. martini has no specific indication. The study suggests that including these plants in clinical practice in Brazil could expand the available therapeutic options, especially considering the growing incidence of diabetes in the country, which may affect 23.3 million Brazilians by 2040, according to the International Diabetes Federation. The research highlights the need for additional safety and efficacy evaluations for the regulation of the use of these plants in Brazil.
Key points
- 81 plant species from the API have indication for Prameha, reflecting metabolic disorders similar to Diabetes Mellitus.
- Curcuma longa and Cymbopogon martini are the only plants common to both pharmacopoeias, but with different indications.
- C. longa is recognized in the BP for its anti-inflammatory and anti-dyspeptic properties, while C. martini has no specific indication.
- The API has 394 plant species, of which only 81 are relevant for Prameha, indicating a potential for expanding the use of herbal medicines in Brazil.
- The inclusion of API plants in Brazilian clinical practice may help address the diabetes epidemic.
✦ For you
If you are concerned about metabolic health, consider including spices like turmeric (Curcuma longa) in your diet, as it is recognized for its anti-inflammatory properties. Additionally, observe how your body reacts to different foods and habits, especially if you have a family history of diabetes. If you notice persistent symptoms, seek a qualified healthcare professional.
For practitionersExpand
Consider including Curcuma longa in formulas for patients with metabolic disorders, especially those at risk for diabetes. Evaluate the possibility of integrating plants from the Ayurvedic Pharmacopoeia into clinical practice, but always with due consideration for safety and efficacy. Stay updated on local regulations for the use of herbal medicines.